CD274 and multiple sclerosis: Moreover, limiting multiple sclerosis progression was also seen by the targeting of lymphocytes by limiting their activation, proliferation, and secretion of inflammatory agents using BMSC-exos loaded with Programmed Cell Death Ligand 1 (PD-L1), TGF-β, and galectin (GAL)-1 [180,181].